Lv21
160 积分 2024-06-21 加入
Tumor-associated macrophage (TAM)-secreted CCL22 confers cisplatin resistance of esophageal squamous cell carcinoma (ESCC) cells via regulating the activity of diacylglycerol kinase α (DGKα)/NOX4 axis
1个月前
已完结
Tumor-Derived CCL5 Recruits Cancer-Associated Fibroblasts and Promotes Tumor Cell Proliferation in Esophageal Squamous Cell Carcinoma
2个月前
已完结
A milestone in epithelial–mesenchymal transition
3个月前
已完结
Management of Lymph Node–positive Penile Cancer: A Systematic Review
3个月前
已完结
Reconciling the discrepancies in randomized data of combining immunotherapy and radiation therapy: Not all radiotherapy is created equal
4个月前
已完结
Solving the Stereotactic Body Radiotherapy and Checkpoint Inhibitor Puzzle in Metastatic Renal Cell Carcinoma
4个月前
已完结
Phase I Study of Stereotactic Body Radiotherapy followed by Ipilimumab with Nivolumab vs. Nivolumab alone in Unresectable Hepatocellular Carcinoma
5个月前
已完结
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium
5个月前
已完结
Reconciling the Discrepancies in Randomized Data of Combining Immunotherapy and Radiation Therapy: Not all Radiotherapy is Created Equal
5个月前
已完结
皖公网安备34019202002308
